A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
| Listen: | Note: There is multimedia content on this page which requires the Flash viewer. To see it, download and install the Flash plugin here: Macromedia Flash Player |
 |
Overview: A diagnosis of brain cancer can be devastating. An estimated 19,000 people in the United States are diagnosed each year with a malignant tumor that originates in the brain, and many thousands more develop secondary cancers that have spread to the brain from other parts of the body.
In this Medically Speaking podcast, Dr. William F. Regine, chief of radiation oncology and interim chair of diagnostic radiology and nuclear medicine at the University of Maryland Medical Center and professor and chairman of radiation oncology at the University of Maryland School of Medicine, says brain cancer patients have a better chance of survival when they are able to have surgery. Whether a tumor is operable depends on its location within the brain, he says.
In this interview with Karen Warmkessel, Dr. Regine says that most patients
also receive chemotherapy and targeted radiation. An oral chemotherapy drug
called Temodar has significantly improved survival, particularly when it is
combined with radiation.
We would like your feedback about Medically Speaking. If you'd like to contact us, please e-mail media@umm.edu.
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System, 22 S. Greene
Street, Baltimore, MD 21201. 1.800.492.5538 TDD: 1.800.735.2258
Physician Referral: 1.800.373.4111
Click to Print
Print Preview
